Covid magnified a growing mental health crisis for college students How are administrators & community groups responding? kalw.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kalw.org Daily Mail and Mail on Sunday newspapers.
E-Mail
On Wednesday, March 3, the University of Minnesota will host top national experts to debate how COVID-19 is changing the rules and conduct for research. This webinar on Conducting Research in the COVID-19 Pandemic: Ethics in an Emergency will tackle huge issues, including:
How can research successfully include the Black, Indigenous, and other vulnerable populations who are being hit so hard by the pandemic? What steps will make research genuinely responsive to the needs of those communities?
How can health professionals simultaneously collect data ethically, try to save each patient s life, and allocate scarce medications? Most currently available treatments are not FDA-approved, and instead are available under Emergency Use Authorizations (EUAs). Collecting data is essential, but so are saving lives and allocating medications ethically.
In early December, the House of Representatives passed the Marijuana Opportunity Reinvestment and Expungement Act, or the MORE Act.
The bill sought to decriminalize marijuana nationally by removing cannabis from the federal government’s Schedule I controlled substance list. That category indicates the drug has high potential for abuse and no therapeutic value. It also includes drugs like methamphetamine and heroin.
The bill is a long way from passage. With a new Congress just seated, it would need to be reintroduced and pass again in the House. Even if that happens, it is unlikely to get through the Senate.
Still, the initial success of the MORE Act is an important sign that sentiment in Washington is changing, guided by increasing public backing for cannabis reform. Two-thirds of Americans now support legalizing the drug.